Inappropriate treatment for COPD leads to high direct costs in Spain

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.469, 2005-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs

By Krigsman Kristin Melander Arne Carlsten Anders Ekedahl Anders Nilsson J.

Pharmacy World and Science, Vol. 29, Iss. 1, 2007-02 ,pp. : 19-24

Springer Publishing Company

Access to resources Recommend Favorite

The Burden of Migraine in Spain: Beyond Direct Costs

By Badia X.

PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. : 591-603

Adis International

Access to resources Recommend Favorite

Potentially inappropriate prescriptions raise costs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 597, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Smoking in COPD: from costs to quitting

Inpharma, Vol. 1, Iss. 1261, 2000-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Smoking in COPD: from costs to quitting

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 287, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite